U.S. markets closed

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed Price. Currency in USD
50.25+0.29 (+0.58%)
At close: 04:00PM EDT
50.27 +0.02 (+0.04%)
After hours: 06:28PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close49.96
Bid49.25 x 800
Ask51.25 x 800
Day's Range49.90 - 50.74
52 Week Range48.86 - 80.04
Avg. Volume1,709,885
Market Cap7.024B
Beta (5Y Monthly)1.08
PE Ratio (TTM)24.88
EPS (TTM)2.02
Earnings DateNov 06, 2023 - Nov 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est66.36
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for GMED

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Globus Medical, Inc.
    GMED: Lowering target price to $52.00GLOBUS MEDICAL INC - A has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • GlobeNewswire

    Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023

    AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt. “As leaders in the musculoskeletal device industry, we are committed to procedurally integrated innovation that enables surgeons to deliver more intelligent surgery,” said Dan Scavilla, chief executive officer at Globus Me

  • The Fly

    Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls

    Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls


    Dell a buy on AI and bolstered demand: 5 big analyst picks

    Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for Super Micro Computer, and upgrades for Dell, CVS, Globus Medical , and Rackspace Technology. Dell (NYSE:DELL) shares were rising nearly 2% pre-market Tuesday after Daiwa Securities upgraded the PC maker to Outperform from Neutral and raised its price target to $80.00 from $50.00, as reported in real time on InvestingPro. The analysts noted that Dell's Q2/24 earnings report last month exceeded consensus expectations with strong revenue of $22.9 billion, which beat estimates by $2.1B.